Increased CD28 expression has been shown to correlate with improved survival in head and neck squamous cell carcinoma (HNSCC), while increased FLT3LG expression has previously been shown to correlate with improved survival in cervical cancer [28,44]. The gene discussed is CD28; the disease is cervical carcinoma.